PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
11-Beta-Hydroxylase 721 Target Disease Asthma 109,610 1 0.00 -1.00 0.00 0.51
11-Beta-Hydroxylase 721 Target Disease Heart Disease 118,291 1 0.00 -1.00 0.00 0.50
11-Beta-Hydroxylase 721 Target Disease Inflammation 252,734 1 0.00 -1.00 0.00 0.49
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Target Calcium Dependent Atpase 105 1 0.01 -0.99 0.01 0.72
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Target ANGPTL4 289 1 0.00 -1.00 0.00 0.70
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Target AKT3 293 1 0.00 -1.00 0.00 0.70
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Target ADRP 537 1 0.00 -1.00 0.00 0.67
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Target AKT2 873 1 0.00 -1.00 0.00 0.66
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Drug Doxazosin 1,316 1 0.00 -1.00 0.00 0.64
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Viral Disease 2,087 1 0.00 -1.00 0.00 0.63
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Familial Adenomatous Polyposis 3,742 1 0.00 -1.00 0.00 0.61
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Testicular Cancer 4,459 1 0.00 -1.00 0.00 0.61
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Mesothelioma 11,198 1 0.00 -1.00 0.00 0.58
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Diabetic Nephropathy 12,496 1 0.00 -1.00 0.00 0.58
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Target Phospholipase A2 13,400 1 0.00 -1.00 0.00 0.58
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Lung Carcinoma 13,423 1 0.00 -1.00 0.00 0.58
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Drug Doxorubicin 28,033 1 0.00 -1.00 0.00 0.56
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Ovarian Cancer 33,996 1 0.00 -1.00 0.00 0.55
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Anxiety 113,510 1 0.00 -1.00 0.00 0.53
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Cholesterol 182,390 1 0.00 -1.00 0.00 0.52
4-1BB Ligand 135 Target Target BTK 1,263 1 0.00 -1.00 0.01 0.65
4-1BB Ligand 135 Target Target CCL3 1,427 1 0.00 -1.00 0.01 0.65
4-1BB Ligand 135 Target Disease Myelodysplastic Syndrome 7,378 1 0.00 -1.00 0.01 0.60
4-1BB Ligand 135 Target Disease Organ Transplantation 11,384 1 0.00 -1.00 0.01 0.59
4-1BB Ligand 135 Target Disease Chronic Lymphocytic Leukemia 11,642 1 0.00 -1.00 0.01 0.59
4-1BB Ligand 135 Target Disease Leukemias 14,152 1 0.00 -1.00 0.01 0.59
4-1BB Ligand 135 Target Disease Multiple Myeloma 24,594 1 0.00 -1.00 0.01 0.57
4-1BB Ligand 135 Target Drug Doxorubicin 28,033 1 0.00 -1.00 0.01 0.57
4-1BB Ligand 135 Target Disease Sepsis 64,798 1 0.00 -1.00 0.01 0.55
4-1BB Ligand 135 Target Disease Rheumatoid Arthritis 78,952 1 0.00 -1.00 0.01 0.55
4-1BB Ligand 135 Target Disease Asthma 109,610 1 0.00 -1.00 0.01 0.54
4-1BB Ligand 135 Target Disease Arthritis 128,324 1 0.00 -1.00 0.01 0.53
4-1BB Ligand 135 Target Target Collagen 138,882 1 0.00 -1.00 0.01 0.53
4-1BB Ligand 135 Target Disease Breast Cancer 173,695 1 0.00 -1.00 0.01 0.53
4-1BB Receptor 20 Target Disease Conjunctivitis 8,825 1 0.00 -0.97 0.05 0.63
4-1BB Receptor 20 Target Disease Lung Carcinoma 13,423 1 0.00 -0.97 0.05 0.62
4-1BB Receptor 20 Target Disease Influenza 67,933 1 0.00 -0.97 0.05 0.58
4-1BB Receptor 20 Target Disease Shock 134,031 1 0.00 -0.97 0.05 0.57
4-1BB Receptor 20 Target Target Collagen 138,882 1 0.00 -0.97 0.05 0.57
4-1BB Receptor 20 Target Disease Tuberculosis 146,217 1 0.00 -0.97 0.05 0.56
4-1BB Receptor 20 Target Disease Leukemia 162,805 1 0.00 -0.97 0.05 0.56
4-1BB Receptor 20 Target Disease Inflammation 252,734 1 0.00 -0.97 0.05 0.55
4-Mercaptobenzoic Acid 70 Drug Disease Malaria 56,215 1 0.00 -0.99 0.01 0.56
4-Mercaptopyridine 96 Drug Disease Glioblastoma 17,933 1 0.00 -0.99 0.01 0.59
4-Mercaptopyridine 96 Drug Drug Doxorubicin 28,033 1 0.00 -0.99 0.01 0.58
4-Mercaptopyridine 96 Drug Disease Cancer 1,053,491 1 0.00 -0.99 0.01 0.50
464.1 19 Target Disease Hypotension 42,123 1 0.00 -0.97 0.05 0.59
464.1 19 Target Disease Asthma 109,610 1 0.00 -0.97 0.05 0.57
464.1 19 Target Disease Leukemia 162,805 1 0.00 -0.97 0.05 0.56
464.1 19 Target Disease Cholesterol 182,390 1 0.00 -0.97 0.05 0.56
464.1 19 Target Disease Inflammation 252,734 1 0.00 -0.97 0.05 0.55
5-Hydroxytryptamine 2a Receptor 67 Target Target Sphingomyelinase 3,060 1 0.00 -0.99 0.01 0.64
5-Hydroxytryptamine 2a Receptor 67 Target Disease Mania 7,698 1 0.00 -0.99 0.01 0.61
5-Hydroxytryptamine 2a Receptor 67 Target Target BDNF 11,163 1 0.00 -0.99 0.01 0.60
5-Hydroxytryptamine 2a Receptor 67 Target Disease Autism 20,962 1 0.00 -0.99 0.01 0.59
5-Hydroxytryptamine 2a Receptor 67 Target Disease Psoriasis 26,882 1 0.00 -0.99 0.01 0.58
5-Hydroxytryptamine 2a Receptor 67 Target Target EGF 27,487 1 0.00 -0.99 0.01 0.58
5-Hydroxytryptamine 2a Receptor 67 Target Disease Seizures 66,465 1 0.00 -0.99 0.01 0.56
5-Hydroxytryptamine 2a Receptor 67 Target Target Collagen 138,882 1 0.00 -0.99 0.01 0.55
5-Hydroxytryptamine 2a Receptor 67 Target Disease Inflammation 252,734 1 0.00 -0.99 0.01 0.53
5-Hydroxytryptamine 2b Receptor 18 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.03 -0.96 0.06 0.79
5-Hydroxytryptamine 2b Receptor 18 Target Disease Central Nervous System Diseases 715 1 0.01 -0.97 0.06 0.70
5-Hydroxytryptamine 2b Receptor 18 Target Target D(2) Dopamine Receptor 1,559 1 0.01 -0.97 0.06 0.68
5-Hydroxytryptamine 2b Receptor 18 Target Target Elastase 13,875 1 0.00 -0.97 0.06 0.62
5-Hydroxytryptamine 2b Receptor 18 Target Disease Amyotrophic Lateral Sclerosis 14,006 1 0.00 -0.97 0.06 0.62
5-Hydroxytryptamine 2b Receptor 18 Target Target ERK1 18,374 1 0.00 -0.97 0.06 0.61
5-Hydroxytryptamine 2b Receptor 18 Target Disease Migraine 24,200 1 0.00 -0.97 0.06 0.61
5-Hydroxytryptamine 2b Receptor 18 Target Disease Liver Disease 49,817 1 0.00 -0.97 0.06 0.59
5-Hydroxytryptamine 2b Receptor 18 Target Disease Obesity 138,233 1 0.00 -0.97 0.06 0.57
744.1 22 Target Target 464.1 19 1 0.05 -0.95 0.05 0.83
744.1 22 Target Disease Acute Promyelocytic Leukemia 4,780 1 0.00 -0.98 0.05 0.64
744.1 22 Target Target Adiponectin 11,994 1 0.00 -0.98 0.05 0.62
744.1 22 Target Disease Dyslipidemia 15,225 1 0.00 -0.98 0.05 0.61
744.1 22 Target Disease Chronic Obstructive Pulmonary Disease 27,780 1 0.00 -0.98 0.05 0.60
744.1 22 Target Disease Liver Disease 49,817 1 0.00 -0.98 0.05 0.59
744.1 22 Target Disease Stroke 146,992 1 0.00 -0.98 0.05 0.56
744.1 22 Target Disease Leukemia 162,805 1 0.00 -0.98 0.05 0.56
744.1 22 Target Disease Hepatitis 163,842 1 0.00 -0.98 0.05 0.56
744.1 22 Target Disease Carcinoma 433,099 1 0.00 -0.98 0.05 0.54
A-Methapred (Methylprednisolone Sodium Succinate)- FDA 1 Drug Drug Adalimumab (Humira)- FDA 62 1 0.13 -0.70 1.00 0.82
A1AT 329 Target Target Macrophage Metalloelastase 100 1 0.01 -0.99 0.01 0.70
A1AT 329 Target Target CALR 117 1 0.01 -0.99 0.01 0.70
A1AT 329 Target Target APOA2 118 1 0.01 -0.99 0.01 0.70
A1AT 329 Target Target Proteinase-Activated Receptor 1 133 1 0.00 -0.99 0.01 0.70
A1AT 329 Target Target APOA1 958 1 0.00 -1.00 0.00 0.65
A1AT 329 Target Disease Rare Diseases 2,212 1 0.00 -1.00 0.00 0.62
A1AT 329 Target Target CER 2,421 1 0.00 -1.00 0.00 0.62
A1AT 329 Target Target CD95 4,266 1 0.00 -1.00 0.00 0.60
A1AT 329 Target Disease Warts 5,574 1 0.00 -1.00 0.00 0.59
A1AT 329 Target Target Alpha-Amylase 7,171 1 0.00 -1.00 0.00 0.59
A1AT 329 Target Disease Ileus 9,091 1 0.00 -1.00 0.00 0.58
A1AT 329 Target Disease Acute Coronary Syndromes 9,133 1 0.00 -1.00 0.00 0.58
A1AT 329 Target Disease Ankylosing Spondylitis 9,665 1 0.00 -1.00 0.00 0.58
A1AT 329 Target Disease Respiratory Tract Infections 9,721 1 0.00 -1.00 0.00 0.58
A1AT 329 Target Disease Down Syndrome 10,290 1 0.00 -1.00 0.00 0.58
A1AT 329 Target Disease Bacterial Infections 14,248 1 0.00 -1.00 0.00 0.57
A1AT 329 Target Disease Nephrotic Syndrome 14,681 1 0.00 -1.00 0.00 0.57
A1AT 329 Target Disease Menopause 19,680 1 0.00 -1.00 0.00 0.56
A1AT 329 Target Target CD34 24,598 1 0.00 -1.00 0.00 0.56
A1AT 329 Target Target EGF 27,487 1 0.00 -1.00 0.00 0.55